[Erythropoietin use by incident hemodialysis patients in the Brazilian Unified National Health System, 2002-2003].
This study aimed to describe the demographic and epidemiological profile of Brazilian patients entering hemodialysis from 2002 to 2003 and identify predictors of erythropoietin use. The study analyzed demographic and clinical characteristics and dialysis facility-related variables from 32,136 patients identified by deterministic-probabilistic matching in the database of authorizations for high-cost procedures and the Mortality Information System. Poisson regression was used to identify predictors of erythropoietin use. Male gender, age < 65 years, diabetic renal failure, arteriovenous fistula at the beginning of hemodialysis, and living in States of Brazil other than Mato Grosso were predictors of erythropoietin use. The policy of care for chronic kidney disease, resource allocation for States and municipalities, and anemia management according to the patient's drug therapy profile need to be revised in order to reduce observed inequities in erythropoietin use.
Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brasil. thaiscarolgurgel@bol.com.br
Thaís Caroline
TC
Gurgel
Mariângela Leal
ML
Cherchiglia
Francisco de Assis
Fde A
Acurcio
Daniele Araújo Campos
DA
Szuster
Isabel Cristina
IC
Gomes
Eli Iola Gurgel
EI
Andrade
D000293:Adolescent; D000328:Adult; D000740:Anemia / Q000188:drug therapy*; D001938:Brazil / Q000453:epidemiology; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000453:epidemiology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D006435:Renal Dialysis; D012307:Risk Factors; D055815:Young Adult
D004921:Erythropoietin